BRAVECTO® is a registered trademark

GHANA: BRAVECTO® Chew Tabs 122,5 mg FDA/V.255-10165 BRAVECTO® Chew Tabs
250 mg FDA/V.255-10163 BRAVECTO® Chew Tabs 500 mg FDA/V.255-10162
BRAVECTO® Chew Tabs 1000 mg FDA/V.255-10166 BRAVECTO® Chew Tabs 1400 mg
FDA/V.255-10164

KENYA: BRAVECTO® 112,5 mg – VMD 2022/303264-III, BRAVECTO® 250 mg – VMD
2019/20314-II, BRAVECTO® 500 mg – VMD 2022/203262-II, BRAVECTO® 1000 mg –
VMD 2022/203263-II, BRAVECTO® 1400 mg – VMD 2022/203261-II.

NAMIBIA: BRAVECTO® V14/18.3.10/1259 [NS0]

NIGERIA: BRAVECTO® Oral Chewable Tablet 112,5 mg Fluralaner Nigeria NAFDAC
Reg. No. A9-100511, BRAVECTO® Oral Chewable Tablet 250 mg Fluralaner Nigeria
NAFDAC Reg. No. A9-100512, BRAVECTO® Oral Chewable Tablet 500 mg Fluralaner
Nigeria NAFDAC Reg. No. A9-100513, BRAVECTO® Oral Chewable Tablet 1 000 mg
Fluralaner Nigeria NAFDAC Reg. No. A9-100514, BRAVECTO® Oral Chewable Tablet 1
400 mg Fluralaner Nigeria NAFDAC Reg. No. A9-100515

SOUTH AFRICA: BRAVECTO® Reg. No. G4083 (Act 36/1947)

UGANDA: BRAVECTO® 112,5 mg – NDA/MAL/VDP/11646, BRAVECTO® 250 mg –
NDA/MAL/VDP/11647, BRAVECTO® 500 mg – NDA/MAL/VDP/11648, BRAVECTO®
1000 mg – NDA/MAL/VDP/11649, BRAVECTO® 1400 mg – NDA/MAL/VDP/11702.
ZIMBABWE: BRAVECTO® tabs 112.5mg: 2017/80.16.00/9754 250 mg:
2019/80.16.00/9787 500 mg: 2019/80.16.00/9788 1000mg: 2019/80.16.00/9789
1400mg: 2019/80.16.00/9790

ZAMBIA: BRAVECTO® Chewable Tablets 112.5 mg. Zamra-vm-23-53, BRAVECTO®
Chewable Tablets 250 mg, Zamra-vm-23-54, BRAVECTO® Chewable Tablets 500 mg,
Zamra-vm-24-16, BRAVECTO® Chewable Tablets 1000 mg, Zamra-vm-23-56
BRAVECTO® Chewable Tablets 1400 mg, Zamra-vm-23-55